|
Q-660
|
Monday, December 8, 2025 |
With regard to Crown-Indigenous Relations and Northern Affairs Canada and Indigenous Services Canada: (a) what investigations were undertaken before making the determination that First Nations and Indigenous peoples were designated a priority group to receive the COVID-19 vaccines; (b) who made the recommendation in (a), and who approved the determination; (c) has the Minister of Crown-Indigenous Relations or the Minister of Indigenous Services received any correspondence in the last five years from any First Nations or Indigenous tribunals, either Canadian or international, about the COVID-19 vaccines; (d) if the answer to (c) is affirmative, what was the content of the correspondence and what actions took place; (e) were investigations undertaken by Crown-Indigenous Relations and Northern Affairs Canada or by the Government of Canada to investigate the rates of adverse events, including fatalities, in the First Nations and Indigenous populations following the administration of the COVID-19 vaccine; (f) what information or conclusions were made from the investigations in (e); (g) what action did the Minister of Crown-Indigenous Relations or the Minister of Indigenous Services take to protect First Nations and Indigenous populations once it was discovered that the mRNA injections were contaminated with excess deoxyribonucleic acid combined with an SV40 nuclear targeting agent; (h) did Crown-Indigenous Relations and Northern Affairs Canada receive any funding to promote the COVID-19 vaccines to the First Nations and Indigenous population, and, if so, how much and from what source; (i) did any or all bands receive funding specifically in relation to the COVID-19 vaccine; (j) if the answer to (i) is affirmative, how much funding was received by each band, was the funding contingent on specific compliance regarding the COVID-19 vaccine or its promotion, and, if so, what were those conditions; (k) if the answer to (i) is affirmative, who or what agency provided the funding, and was any funding directed towards (i) preventing vaccine hesitancy, (ii) promoting awareness of adverse reactions, (iii) other, and how much was allocated for (i), (ii) and (iii); (l) in relation to the Vaccine Injury Support Program, (i) how many First Nations and Indigenous persons have applied to the Vaccine Injury Support Program, (ii) how many applications have been accepted, (iii) how many fatalities have been recorded in this population, (iv) how much money in total has been awarded through this program to First Nations and Indigenous persons; (m) if the answer to (l) is negative, is there another application process or vaccine injury support program specifically for First Nations and Indigenous persons who have suffered a vaccine injury or fatality; and (n) if the answer to (m) is affirmative, (i) what is the name of the program, (ii) how many First Nations and Indigenous persons have applied to this program, (iii) how many applications have been accepted, (iv) how many fatalities have been recorded in this population, (v) how much money in total has been awarded through this program? |
Awaiting response |
Monday, January 26, 2026 |
|
Q-535
|
Friday, October 24, 2025 |
With regard to the Indigenous Art Collection managed by the Indigenous Art Centre: (a) how many artworks from the collection are currently unaccounted for; and (b) for each unaccounted-for artwork, (i) what is the title, (ii) who are the artists, (iii) what is the estimated value, (iv) when was it last verified or inventoried, (v) what was its last documented location, (vi) have the artists been informed of its unaccounted-for status? |
Answered |
Wednesday, December 10, 2025 |
|
Q-72
|
Friday, May 30, 2025 |
With regard to Sustainable Development Technology Canada: (a) what are the costs incurred by the (i) board of directors, (ii) executive team, since January 1, 2016, broken down by year and month; (b) what is the breakdown of (a) by type of expense, including the amount spent on meeting spaces, travel claims, hospitality bills, honorariums, etc.; (c) what are the details of each travel expense incurred by the board or executive, including the (i) travel destination, (ii) date, (iii) total expenditures, (iv) name and title of the traveller; (d) what are the details of all hospitality expenses incurred by the board or executive, including the (i) date, (ii) amount, (iii) location, (iv) vendor, (v) event description, (vi) names and titles of the attendees; and (e) how much was paid in honorariums to the board, broken down by year? |
Answered |
Monday, September 15, 2025 |
|
Q-71
|
Friday, May 30, 2025 |
With regard to spending on informatics services, in 2022-23, as listed in table 2 of the Parliamentary Budget Officer's report titled "Fiscal cost of task-based IT contracting": (a) what is the total amount spent on contracts for all departments, agencies and Crown corporations; and (b) what are the details of all such contracts, including, for each, (i) the amount, (ii) the vendor, (iii) the date and duration, (iv) the description of the goods or services provided, (v) the topics related to the goods or services, (vi) the specific goals or objectives related to the contract, (vii) whether the goals or objectives were met, (viii) whether the contract was sole-sourced or awarded through a competitive bidding process? |
Answered |
Monday, September 15, 2025 |
